Cargando…

CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands

The peroxisome proliferator-activated receptor γ (PPARγ) ligands are important therapeutic drugs for the treatment of type 2 diabetes, obesity and cardiovascular diseases. In particular, partial agonists and non-agonists are interesting targets to reduce glucose levels, presenting few side effects i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mottin, Melina, Souza, Paulo C. T., Ricci, Clarisse G., Skaf, Munir S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297650/ https://www.ncbi.nlm.nih.gov/pubmed/28025495 http://dx.doi.org/10.3390/ijms18010015

Ejemplares similares

charmm2gmx: An Automated Method to Port the CHARMM Additive Force Field to GROMACS
por: Wacha, András F., et al.
Publicado: (2023)

CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field
por: Lee, Jumin, et al.
Publicado: (2015)

GQ-16, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand, Promotes Insulin Sensitization without Weight Gain
por: Amato, Angélica A., et al.
Publicado: (2012)

Additive CHARMM force field for naturally occurring modified ribonucleotides
por: Xu, You, et al.
Publicado: (2016)

Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields
por: Allen, Caley, et al.
Publicado: (2022)

Parameterization to NDDO-based polarizable force field
por: Thomas, Heike, et al.
Publicado: (2014)

Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum
por: Edwards, Lariah, et al.
Publicado: (2019)

Ligands of the peroxisome proliferator-activated receptor γ inhibit hepatoce llular carcinoma cell proliferation
por: Jin, Zhe, et al.
Publicado: (2017)

Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex
por: Ricci, Clarisse G., et al.
Publicado: (2016)

Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γ Ligands in Lung Cancer
por: Nemenoff, Raphael A., et al.
Publicado: (2008)

Parameterization and optimization of the menthol force field for molecular dynamics simulations
por: Jasik, Mateusz, et al.
Publicado: (2016)

Data analysis of molecular dynamics simulation trajectories of β-sitosterol, sonidegib and cholesterol in smoothened protein with the CHARMM36 force field
por: Che Omar, Mohammad Tasyriq
Publicado: (2020)

Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma
por: Rumi, M A K, et al.
Publicado: (2001)

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists
por: Liberato, Marcelo Vizoná, et al.
Publicado: (2012)

PROTDES: CHARMM toolbox for computational protein design
por: Suárez, María, et al.
Publicado: (2009)

New faster CHARMM molecular dynamics engine
por: Hynninen, Antti-Pekka, et al.
Publicado: (2014)

Validating the CHARMM36m protein force field with LJ-PME reveals altered hydrogen bonding dynamics under elevated pressures
por: Xu, You, et al.
Publicado: (2021)

Protein–Ligand Binding Free-Energy Calculations with ARROW—A Purely First-Principles Parameterized Polarizable Force Field
por: Nawrocki, Grzegorz, et al.
Publicado: (2022)

POSSIM: Parameterizing Complete Second-Order Polarizable Force Field for Proteins
por: Li, Xinbi, et al.
Publicado: (2014)

Utilizing systems biology to reveal cellular responses to peroxisome proliferator-activated receptor γ ligand exposure
por: Cheng, Vanessa, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

CHARMM-GUI-Based Induced Fit Docking Workflow to Generate Reliable Protein–Ligand Binding Modes
por: Guterres, Hugo, et al.
Publicado: (2023)

Simulations of lipid bilayers using the CHARMM36 force field with the TIP3P-FB and TIP4P-FB water models
por: Sajadi, Fatima, et al.
Publicado: (2018)

Biomolecular Force Field Parameterization via Atoms-in-Molecule Electron Density Partitioning
por: Cole, Daniel J., et al.
Publicado: (2016)

Force Field Parameterization for the Description of the Interactions between Hydroxypropyl-β-Cyclodextrin and Proteins
por: Arsiccio, Andrea, et al.
Publicado: (2021)

Self-Consistent Parameterization of DNA Residues for the Non-Polarizable AMBER Force Fields
por: Schneider, Amelia L., et al.
Publicado: (2022)

Ligand Binding Reduces SUMOylation of the Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation Function 1 (AF1) Domain
por: Diezko, Rolf, et al.
Publicado: (2013)

Peroxisome Proliferator-Activated Receptor-γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer
por: Giaginis, Costas, et al.
Publicado: (2008)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
por: Ohshima, Kousei, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
por: Liu, Huang-Jun, et al.
Publicado: (2016)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
por: Zhang, Su, et al.
Publicado: (2015)

Effect of peroxisome proliferator-activated receptor γ on inflammatory markers
por: Khazaei, Majid
Publicado: (2015)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Evaluation of nine condensed-phase force fields of the GROMOS, CHARMM, OPLS, AMBER, and OpenFF families against experimental cross-solvation free energies
por: Kashefolgheta, Sadra, et al.
Publicado: (2021)

Extending the Stochastic Titration CpHMD to CHARMM36m
por: Sequeira, João G. N., et al.
Publicado: (2022)

Troglitazone, a Ligand for Peroxisome Proliferator‐activated Receptor γ Inhibits Chemically‐induced Aberrant Crypt Foci in Rats
por: Kohno, Hiroyuki, et al.
Publicado: (2001)

Flexible Force Field Parameterization through Fitting on the Ab Initio-Derived Elastic Tensor
por: Heinen, Jurn, et al.
Publicado: (2017)

Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo
por: Yamamoto, Atsuki, et al.
Publicado: (2011)

Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

Parameterization of the LHCb Magnetic Field Map
por: Keune, A
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_c5qgil1a93ebolgok6ndnh5ho1